Ketamine infiltration decreases opioid requirement after thyroid surgery
Phase 4
- Conditions
- Ear, Nose and Throat
- Registration Number
- PACTR202210634713270
- Lead Sponsor
- Habib Bourguiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Patients aged 18 to 65 who scheduled thyroid surgery were included in this study if they had an ASA score (American Society of Anesthesiology) of I or II.
Patients with unstable diabetes, an allergy to study drugs, a history of previous cervical surgery, or a history of cardiac or respiratory disease, as well as patients on long-term analgesic or corticosteroids, were not included in this study.
Exclusion Criteria
Patients who had major complications, such as allergic reactions to anesthetic drugs and major bleeding
Patients whose surgery duration exceeded 3 hours were excluded from this study.
Patients who underwent a neck dissection associated with thyroid surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcomes were to determine the intensity of the pain using VAS in 0-100 in the first 24 hours.
- Secondary Outcome Measures
Name Time Method Opioid requirements were recorded during the PACU admission period. The occurrence of side effects of opioid and ketamine was noted.